Articles tagged with: AIDSmap

Many gay/bisexual men currently taking PrEP would switch to injectable forms of the therapy should it become available

published: October, 12, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , African, Caribbean and Black, Gay Men, Treatment Guidelines -including when to start, Research, Sexual Health, Health, International , Treatment, Media, Revolving Door, Guest Authors

"It removes the requirement to take daily treatment and the need to maintain high levels of treatment adherence." From AIDSmap, Michael Carter reports.

Many gay/bisexual men currently taking PrEP would switch to injectable forms of the therapy should it become available

Approximately a third of gay and bisexual men who are currently taking oral (tenofovir/emtricitabine) pre-exposure prophylaxis (PrEP) would prefer long-acting injectable PrEP should it become available, investigators report in AIDS and Behavior. Individuals were less likely to prefer injectable PrEP if they had concerns about the level of protection it provided against HIV and/or about its durability. “About one-third of GBM [gay and bisexual men] currently taking oral PrEP would prefer LA

Virally suppressed people have “effectively no risk” of transmitting HIV, says US CDC: but how many are suppressed?

published: October, 06, 2017 Categories // Social Media, As Prevention , African, Caribbean and Black, Gay Men, Treatment Guidelines -including when to start, Current Affairs, International , Treatment, Media, Revolving Door, Guest Authors

Over 60% of gay men have viral suppression, but less than 30% of under 25s. From AIDSmap, Gus Cairns reports.

Virally suppressed people have “effectively no risk” of transmitting HIV, says US CDC: but how many are suppressed?

The US Centers for Disease Control and Prevention (CDC) used 27 September, National Gay Men’s HIV/AIDS Awareness Day, to announce that HIV diagnoses had fallen in white gay and bisexual men and remained stable among African-American gay men between 2010 and 2014, its last complete year of figures. The CDC went further in its release: for the first time, it attributed this slowing of diagnoses to “the prevention effectiveness of antiretroviral therapy (ART)” and said that data from

Amsterdam PrEP failure patient had unusual course of HIV infection

published: October, 04, 2017 Written by // Guest Authors - Revolving Door Categories // Guest Authors

Researchers speculate that continued PrEP might stop local infections becoming systemic. From AIDSmap, Gus Cairns reports.

Amsterdam PrEP failure patient had unusual course of HIV infection

At last February’s Conference on Retroviruses and Opportunistic Infections (CROI), Dutch clinicians presented a so-far unique case of a man who had apparently become infected with non-drug-resistant HIV while taking pre-exposure prophylaxis (PrEP) consistently. Two previous cases of PrEP failure had been reported, but in both cases, the men concerned had been infected with multidrug-resistant HIV. This case, therefore, raised concerns that PrEP may not be 100% effective. The case has

Depression highly prevalent among people living with HIV in sub-Saharan Africa

published: October, 02, 2017 Written by // Guest Authors - Revolving Door

Globally, the mental health of HIV-positive individuals is an increasing concern. From AIDSmap, Michael Carter reports.

Depression highly prevalent among people living with HIV in sub-Saharan Africa

Depression is very common among people living with HIV in sub-Saharan Africa, according to the results of a systematic review and meta-analysis published in PLOS One. Prevalence ranged between 9 and 32%, but differed between screening tools and also according to antiretroviral therapy (ART) status. Risk factors for depression included economic hardship, female sex and immunosuppression, but there was little consistency between studies. “This analysis of the available most recent literature

Smokers with HIV doing well on treatment now at greater risk of lung cancer than AIDS

published: September, 25, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, Gay Men, Health, International , Smoking Cessation , Living with HIV, Media, Revolving Door, Guest Authors

Just under 60,000 people living with HIV are likely to die of lung cancer by the age of 80 (9.3% of all people with HIV currently in care in the United States), researchers estimate. From AIDSmap, Keith Alcorn reports.

Smokers with HIV doing well on treatment now at greater risk of lung cancer than AIDS

People living with HIV on antiretroviral treatment with fully suppressed viral load who smoke are much more likely to die of lung cancer than HIV-related causes, according to the findings of a modelling study published today in JAMA Internal Medicine. The study suggests that people on successful antiretroviral treatment are between six and thirteen times more likely to die of lung cancer than of any AIDS-related illness, and 10% of all people with HIV who are linked to care will eventually

New US PrEP cost-effectiveness model finds drug prices will need to drop substantially if HIV risk rises, or if adherence is only moderate

published: September, 19, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , African, Caribbean and Black, Gay Men, Youth, Treatment Guidelines -including when to start, Women, International , Treatment, Media, Revolving Door, Guest Authors

"With high adherence, PrEP saves money in high-prevalence populations even at current costs." From AIDSmap, Gus Cairns reports.

New US PrEP cost-effectiveness model finds drug prices will need to drop substantially if HIV risk rises, or if adherence is only moderate

A new US model of the cost-effectiveness of pre-exposure prophylaxis (PrEP) for men who have sex with men (MSM), prepared by researchers at Emory University in Atlanta, finds that taking even one year of PrEP is more cost-effective than measures like kidney dialysis, if it is used by people belonging to populations where HIV prevalence is at least 10%. However, for PrEP to actually save money, relative to the lifetime cost of treating the HIV infections that would otherwise happen, either

What is going on in gay men’s lives when they acquire HIV?

published: September, 12, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, Gay Men, Health, International , Media, Revolving Door, Guest Authors

Combinations of factors at individual, community and structural levels contribute to risk behaviour and HIV infection. From AIDSmap, Roger Pebody reports.

What is going on in gay men’s lives when they acquire HIV?

Gay men in England who have recently become HIV positive describe a complex web of factors which may have contributed to their infection, according to a qualitative study recently published in BMJ Open.“Individuals who experienced multiple stressors, gradually over the life course or more suddenly, were especially vulnerable to HIV and being drawn into sexual risk situations, while the social environment created a context that enabled risk of HIV infection,” the researchers write. Indiv

Who are trans women acquiring HIV from? And are trans women's partners a hidden population?

published: September, 05, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, International AIDS Conference , As Prevention , Treatment Guidelines -including when to start, General Health, Women, Research, Health, International , Treatment, Media, Revolving Door, Guest Authors

Is there a hidden population of heterosexual men who have sex with trans women and who are themselves at high risk of acquiring and transmitting HIV? From AIDSmap, Gus Cairns reports on a study that begs this question and others.

Who are trans women acquiring HIV from? And are trans women's partners a hidden population?

There is a lot we don’t know about trans women’s HIV risk, why they are so vulnerable to HIV and who trans women are acquiring HIV from. A study presented at last month’s 9th International AIDS Society Conference on HIV Science (IAS 2017) attempted to answer these questions, but in the process uncovered another mystery. This is whether there is a hidden population of heterosexual men who have sex with trans women and who are themselves at high risk of acquiring and transmitting HIV. On

What is “successful aging” for people living with HIV?

published: August, 30, 2017 Written by // Guest Authors - Revolving Door Categories // Aging, Social Media, As Prevention , Gay Men, General Health, Treatment Guidelines -including when to start, Mental Health, Health, International , Treatment, Lifestyle, Living with HIV, Media, Revolving Door, Guest Authors

From AIDSmap, Roger Pebody reports on a qualitative study by Ontario researchers on HIV, aging and disability.

What is “successful aging” for people living with HIV?

When Canadian researchers asked HIV-positive people over the age of 50 how they would define “successful ageing”, six key themes emerged – accepting limitations, staying positive, maintaining social support, taking responsibility, living a healthy lifestyle, and engaging in meaningful activities. Writing in the International Journal of STD & AIDS, Patricia Solomon and colleagues note the emphasis on individual control. Clinicians and service providers should work with people livin

Incidence of anal cancer has already peaked among HIV-positive gay men; reductions can be achieved with expanded ART coverage and screening

published: August, 17, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, General Health, Research, Health, International , Media, Revolving Door, Guest Authors

From AIDSmap, Michael Carter reports on the first study to predict the incidence of anal cancer in HIV-positive MSM long term, taking into account cART [combination antiretroviral therapy] coverage and individual CD4 cell trajectories.

Incidence of anal cancer has already peaked among HIV-positive gay men; reductions can be achieved with expanded ART coverage and screening

The incidence of anal cancer among HIV-positive gay men peaked in 2009 and will decline substantially by 2030, even with current levels of antiretroviral therapy (ART) coverage and no cancer-screening programme, Swiss investigators report in AIDS. Further significant reductions would be achieved with 100% treatment coverage and various screening strategies. These would be more effective at preventing cases of anal populationcancer than screening for cervical cancer among women in the gener

[12 3 4 5  >>